Silvia de Sanjosé, Wim Quint, Laia Alemany, D.T. Geraets et al.
Background Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical...
Robert B. Belshe, Peter A. Leone, David I. Bernstein, Anna Wald et al.
BACKGROUND: Two previous studies of a herpes simplex virus type 2 (HSV-2) subunit vaccine containing glycoprotein D in HSV-discordant couples revealed 73% and 74% efficacy against genital disease in women who were negative for both HSV type 1 (HSV-1) and HSV-2 antibodies. Efficacy was not observed i...
Laura A.V. Marlow, Jo Waller, Jane Wardle
BACKGROUND: Ethnic minority women are less likely to attend cervical screening. AIM: To explore self-perceived barriers to cervical screening attendance among ethnic minority women compared to white British women. DESIGN: Qualitative interview study. SETTING: Community groups in ethnically diverse L...
Tomi Akinyemiju
BACKGROUND: Breast and Cervical cancer are the two most common cancers among women in developing countries. Regular screening is the most effective way of ensuring that these cancers are detected at early stages; however few studies have assessed factors that predict cancer screening in developing c...
Sarah Hawkes, Linda Morison, Susan D. Foster, Kaniz Gausia et al.
Background In the control of reproductive-tract infections, including sexually transmitted infections (STIs), in low-income and middle-income countries, WHO recommends syndromic management for individuals with symptoms. This intervention was initially developed in areas where prevalence of such infe...
Annika Antonsson, Cornelia Erfurt, Kristina Hazard, Veroniqa Holmgren et al.
In order to investigate whether previous findings of ubiquitous skin papillomavirus infection in Caucasians apply to populations from other parts of the world, skin swab samples from Bangladesh, Japan, Ethiopia and Zambia were analysed in parallel with Swedish samples. The prevalence of HPV DNA in t...
Syed Akram Hussain, Richard Sullivan
Cancer is predicted to be an increasingly important cause of morbidity and mortality in Bangladesh in the next few decades. The estimated incidence of 12.7 million new cancer cases will rise to 21.4 million by 2030. More than two-thirds of the total expenditure on health is through out-of-pocket pay...
Laura A.V. Marlow, J Wardle, Alice S. Forster, Jo Waller
BACKGROUND: Studies of human papillomavirus (HPV) awareness and HPV vaccine acceptability have included few non-white participants, making it difficult to explore ethnic differences. This study assessed HPV awareness and HPV vaccine acceptability in a sample of women representing the major UK ethnic...
Rengaswamy Sankaranarayanan, Ashrafun Nessa, Pulikattil Okkuru Esmy, Jean-Marie Dangou
The need for simple, cost-effective screening approaches for cervical cancer prevention in low-resource countries has led to the evaluation of visual screening with 3-5% acetic acid. The low reproducibility and wide variation in accuracy reflect the subjective nature of the test. Pooled sensitivity,...
Rakibul M. Islam, Baki Billah, Nassif Hossain, John Oldroyd
Background: Cervical cancer (CCa) and breast cancer (BCa) are the two leading cancers in women worldwide. Early detection and education to promote early diagnosis and screening of CCa and BCa greatly increases the chances for successful treatment and survival. Screening uptake for CCa and BCa in low...
Syed Md Akram Hussain
Bangladesh, at 142 million people, is the ninth most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about two lakh patients newly diagnosed with cancer each year. As an overview, lung cancer and mouth-oropharynx cancer rank as the top two prevalent cancers...
Malcolm A Moore, Yasantha Ariyaratne, Farhana Badar, Yasmin Bhurgri et al.
Pakistan, India, Sri Lanka, Bangladesh, Nepal and Bhutan, with their total population of more than 1,500 million, make up the subcontinent of South Asia. Despite massive diversity across the region, there are sufficient similarities to warrant a collective approach to chronic disease control, includ...
Laura A.V. Marlow, J Wardle, Jo Waller
BACKGROUND: Women from Black, Asian and Minority Ethnic (BAME) backgrounds are less likely to attend cervical screening than White British women. This study explored sociodemographic and attitudinal correlates of cervical screening non-attendance among BAME women. METHODS: Women (30-60 years) were r...
Rengaswamy Sankaranarayanan, Neerja Bhatla, Patti E. Gravitt, Partha Basu et al.
Although one-third of the world cervical cancer burden is endured in India, Bangladesh, Nepal and Sri Lanka, there are important gaps in our knowledge of the distribution and determinants of the disease in addition to inadequate investments in screening, diagnosis and treatment in these countries. P...
Md. Mamun Ali, Kawsar Ahmed, Francis M. Bui, Bikash Kumar Paul et al.
Cervical cancer (CC) is the most common type of cancer in women and remains a significant cause of mortality, particularly in less developed countries, although it can be effectively treated if detected at an early stage. This study aimed to find efficient machine-learning-based classifying models t...